by Jane Schumacher | Mar 4, 2025
A decreasing number of researchers and open positions for infectious disease clinicians and limited residency matches are underlying issues that should be addressed to meet the needs around antimicrobial development and clinical care. Amesh Adalja, MD, FIDSA,...
by Jane Schumacher | Sep 24, 2024
Both public and private sectors should invest in antimicrobial research to attract and retain the best scientists This month, world leaders will gather at the UN General Assembly to address the looming threat of antimicrobial resistance (AMR). They will discuss...
by Jane Schumacher | Sep 18, 2024
Since the dawn of the antibiotic age, opportunistic pathogens have evolved defenses faster than humans can develop drugs to combat them. At the same time, humans have unwittingly given the bugs an advantage through the overuse of antibiotics, allowing pathogens that...
by Jane Schumacher | Sep 4, 2024
The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging. The World Health Organization (WHO) has published its first guidance on antibiotic...
by Jane Schumacher | Aug 21, 2024
Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics. Patients who are immunocompromised rely on antibiotics to avoid devastating infections, and those...
